arXiv·6 AugDoes FLAIR super-resolution erase or hallucinate small white-matter lesions?Preprint: computational studyAI & dataPaper
AAIC 2025 Abstract·11 JanMicrostructural and Water Exchange Alterations in ARIA‐E in a Real‐World Cohort Receiving Anti‐Amyloid TherapyStudy in peopleInterventionsPaper
AAIC 2025 Abstract·10 JanMedial temporal lobe Tau‐Neurodegeneration mismatch from MRI and plasma biomarkers identifies vulnerable and resilient phenotypes with ADStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·9 JanAssociations of ¹⁸ F‐flortaucipir tau PET with quantitative tau histopathology in the medial temporal lobeStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·8 JanEnrichment of patients with concomitant LATE on the Alzheimer's disease continuum: comparing structural and cognitive trajectoriesStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·7 JanSegmentation of medial temporal lobe subregions in a nearly isotropic space using T2‐weighted MRI with anisotropic resolutionStudy in peopleAI & dataPaper
AAIC 2025 Abstract·26 DecExploring the Influence of SSDOH and Self‐Identified Race on Resilience and Vulnerability using Machine Learning for NACC UDSComputational studyBiomarkersPaper
AAIC 2025 Abstract·26 DecTau Cognitive Mismatch in Alzheimer's Disease Predicts Presence of Co‐Pathology and Diverging Disease TrajectoryStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·26 DecAssociations between Quantitative Neuronal Loss Measures and Postmortem MRI Atrophy Measures in the Human Medial Temporal Lobe in AD and LATEStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecMonitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment ToolTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecA resource of data and samples in cognitively unimpaired 60–75‐year‐olds at increased risk of Alzheimer's disease based on their APOE4 status as heterozygotes or homozygotesTrial in peopleAI & dataPaper
AAIC 2025 Abstract·24 DecA resource of data and samples in cognitively unimpaired persons at six levels of Alzheimer's disease risk based on their APOE genotypeStudy in peopleAI & dataPaper
AAIC 2025 Abstract·23 DecMonitoring Cognition in Patients Undergoing Anti‐Amyloid Therapies with A Remote App‐Based Digital Cognitive Assessment ToolTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecMedial temporal lobe Tau‐Neurodegeneration mismatch from MRI and plasma biomarkers identifies vulnerable and resilient phenotypes with ADStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecMicrostructural and Water Exchange Alterations in ARIA‐E in a Real‐World Cohort Receiving Anti‐Amyloid TherapyStudy in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecEnrichment of patients with concomitant LATE on the Alzheimer’s disease continuum: comparing structural and cognitive trajectoriesStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecAssociations of ¹⁸ F‐flortaucipir tau PET with quantitative tau histopathology in the medial temporal lobeStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecDeveloping a novel metric of atypicality in Alzheimer's Disease regional volume changesStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecSegmentation and Quantification of Perivascular Spaces in Early Alzheimer’s Disease using Ultra‐long TE T2‐weighted MRIStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecPersonalized Monitoring of Response to Anti‐Amyloid Therapy in a Real‐World Cohort using Clinical Assessment and Plasma BiomarkersTrial in peopleInterventionsPaper